Researchers have recently shown that mice treated with vector constructs that were able to encode for interleukin-2 (IL-2) (Mizuno et al., 2000), IL-4 (Post et al., 2007), or IL-12 (Stanford et al., 2007) cytokines presented a rapid and sustained tumor regression. Here, IL2 is linked to neoplasm.